MarketCap
Facebook
X
TelegramAnnual report 2025
added 01-12-2026
Anixa Biosciences ROE Ratio 2011-2026 | ANIX
Annual ROE Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.07 | -62.78 | -40.31 | -46.8 | -36.55 | -122.12 | -242.02 | -270.01 | -63.22 | -508.01 | -27.29 | -239.58 | 303.56 | 356.16 | -697.34 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 356.16 | -697.34 | -117.89 |
Quarterly ROE Ratio Anixa Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62.65 | -62.94 | -42.97 | -53.18 | -47.56 | -42.49 | -27.67 | -62.51 | -61.18 | -63.63 | -71.24 | -61.63 | -64.84 | -60.32 | -91.7 | -155.44 | -172.59 | -195.95 | -238.98 | -332.61 | -344.25 | -363.3 | -301.22 | -281.49 | -341.39 | -317.57 | -194.78 | -72.6 | 5.53 | 32.92 | -105.67 | -466.89 | -556.02 | -686.85 | -597.05 | -196.85 | -116.78 | -32.24 | -13.92 | -173.15 | -131.19 | -167.98 | -73.5 | 302.86 | 370.37 | 525.99 | 247.68 | 188.07 | 163.01 | 161.88 | 18.13 | -401.51 | -621.82 | -553.09 | -263.83 | -167.62 | -121.64 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 525.99 | -686.85 | -133.68 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 22.32 | -3.71 % | $ 99.4 M |  Israel |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.45 | -3.67 % | $ 1.84 M | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 30.5 | -4.72 % | $ 328 M |  China |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Castle Biosciences
CSTL
|
4.0 | $ 40.78 | 1.92 % | $ 1.13 B | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
DexCom
DXCM
|
26.18 | $ 70.44 | 1.29 % | $ 27.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Guardant Health
GH
|
312.48 | $ 113.62 | 1.32 % | $ 13.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 147.36 | 4.03 % | $ 23.4 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.08 | 0.35 % | $ 1.08 B | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 234.95 | -0.44 % | $ 172 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 105.63 | -1.25 % | $ 4.17 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 12.48 | 0.28 % | $ 354 M | Israel |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 27.65 | -1.53 % | $ 836 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 102.21 | -0.22 % | $ 18.9 B | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.02 | 2.75 % | $ 4.57 B | USA |
 |
Medpace Holdings
MEDP
|
48.98 | $ 602.32 | -1.41 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 234.18 | -1.47 % | $ 42.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.28 | 0.27 % | $ 2.01 B | USA |
 |
National Research Corporation
NRC
|
63.26 | $ 22.06 | -0.72 % | $ 541 M | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 219.04 | -0.3 % | $ 11.3 B | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.3 | 1.56 % | $ 902 M | USA |
 |
Pacific Biosciences of California
PACB
|
-43.74 | $ 2.36 | 6.79 % | $ 599 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 188.87 | -0.33 % | $ 21 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 8.85 | 12.25 % | $ 1.15 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 409.56 | -3.5 % | $ 29.9 B |  Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 272.02 | 0.42 % | $ 22.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 176.57 | -3.31 % | $ 14.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 688.67 | -3.73 % | $ 56.8 B | USA |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 5.65 | -4.56 % | $ 512 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 4.67 | -2.3 % | $ 2.51 M | USA |
 |
Agilent Technologies
A
|
22.45 | $ 135.52 | -2.95 % | $ 41.2 B | USA |